Most dermal-filler side effects are temporary, but fillers also carry uncommon complications that can be serious. Expected short-term reactions include swelling, bruising, redness, tenderness, itching, and temporary firmness. Other problems include infection, persistent nodules, inflammatory reactions, migration, and an unsatisfactory contour. The most serious risk is unintended injection into a blood vessel, which can interrupt circulation and cause skin necrosis, vision loss, or stroke. Some complications appear immediately, while delayed reactions can occur weeks or months later. Severe pain, white, gray, blue, or mottled skin, visual symptoms, or neurologic symptoms require urgent medical evaluation rather than routine follow-up.
Key Takeaways
- Bruising, swelling, tenderness, redness, and temporary firmness are common and usually improve over days to weeks.
- Vascular occlusion is uncommon but potentially severe because compromised blood flow can damage skin, the eye, or the brain.
- New swelling or nodules can develop after the original treatment has already healed.
- Hyaluronic acid filler can often be reduced with hyaluronidase; other filler materials may be considerably harder to remove.
- Risk depends on the treatment area, product, injection plane, volume, anatomy, technique, medical history, and complication preparedness.
What are the common side effects of dermal fillers?
The most common reactions occur at the injection site. The FDA dermal-filler safety guidance lists bruising, redness, swelling, pain, tenderness, itching, and rash among recognized risks. Many resolve within several days to weeks.
Early swelling can also make the area look temporarily larger or less symmetric than the eventual result. Small areas of firmness may be noticeable while the surrounding tissue settles.
The Adonis guide to filler settling time explains why the first few days are usually a poor time to judge final size and symmetry.
| Finding | Typical timing | What it may mean |
|---|---|---|
| Swelling, bruising, tenderness | Hours to days | Common post-injection response |
| Temporary firmness or palpable areas | Days to weeks | May improve as swelling resolves |
| Increasing redness, warmth, drainage | Days or later | Possible infection or inflammatory problem |
| Persistent or delayed nodules | Weeks to months | Requires diagnosis before treatment |
| Sudden pain or abnormal skin color | Usually immediate or early | Possible vascular compromise |
| Vision or neurologic symptoms | Usually immediate or early | Medical emergency |
What is vascular occlusion from dermal filler?
Vascular occlusion occurs when filler enters a blood vessel or interferes enough with circulation to deprive tissue of adequate blood flow. It is the complication that most changes the safety discussion because delayed recognition can lead to permanent injury.
The FDA identifies unintended intravascular injection as the most concerning filler risk. Reported consequences include tissue necrosis, visual abnormalities including blindness, stroke, and, rarely, death.
A 2025 review of vascular filler complications describes a possible progression from early blanching to mottling, discoloration, ischemia, and necrosis. The review emphasizes facial vascular anatomy and careful technique because even small amounts of filler in the wrong vessel can have serious consequences.
What symptoms can indicate a vascular complication?
Symptoms that should raise concern include unusual or escalating pain, skin that becomes pale or blanched, gray or blue coloration, mottling, cool skin, or rapidly worsening changes around the treated area.
Those symptoms are different from ordinary mild tenderness and bruising. The direction of change matters. Routine post-injection symptoms generally improve. Ischemic symptoms can intensify or develop an abnormal color pattern.
Do not apply a “wait for it to settle” rule to vascular warning signs. Severe pain, abnormal skin color, visual changes, or neurologic symptoms require immediate evaluation.
Can dermal filler cause blindness?
Yes, although this complication is uncommon. Filler can enter a facial artery and reach vessels connected to the ophthalmic circulation, interrupting blood flow to the retina or optic nerve.
A 2025 American Academy of Ophthalmology evidence review identified 198 published cases of vision loss caused by accidental intravascular soft-tissue filler injection. Hyaluronic acid was involved in 164 cases, or 83%, and the central and upper midface accounted for most reported injection sites.
The same review found that reported interventions usually did not restore vision. That is why visual symptoms after filler must be treated as an emergency rather than relying on the fact that HA filler can be dissolved elsewhere in the face.
What eye symptoms need immediate attention?
Sudden blurred vision, partial or complete loss of vision, double vision, eyelid drooping, abnormal eye movement, severe ocular pain, or other new visual symptoms after facial filler need immediate medical evaluation.
Patients should not drive themselves to routine office follow-up or wait overnight to see whether the symptom improves.
The FDA likewise advises immediate medical attention for vision changes during or shortly after filler treatment.
Can dermal fillers cause stroke?
Stroke has been reported after intravascular filler injection and is included in FDA safety warnings.
The proposed mechanism involves filler entering arterial circulation and reaching vessels supplying the brain. Sudden weakness, numbness, facial droop, speech difficulty, confusion, severe headache, dizziness, trouble walking, or other acute neurologic changes require emergency care.
This complication is rare, but rarity does not make neurologic symptoms appropriate for observation at home.
What are delayed inflammatory reactions?
Some filler complications occur after the early swelling and bruising have resolved.
Delayed inflammatory reactions may present as new swelling, redness, firmness, tenderness, or nodules in an area treated weeks or months earlier. A 2026 review and cohort study of delayed reactions to HA fillers describes several possible contributors, including immune activation, bacterial contamination, and changes in filler material over time.
This is why new swelling months later should not be called “normal settling.” The provider needs to determine whether the problem is inflammatory, infectious, mechanical, or related to another cause before deciding on treatment.
Are lumps and nodules after filler dangerous?
Not every lump is dangerous. Early firmness can occur as swelling resolves, especially in thin or highly mobile tissue.
A persistent or delayed nodule is different. Possible explanations include superficial product placement, non-inflammatory filler accumulation, infection, granulomatous inflammation, or another immune response.
Increasing pain, heat, redness, drainage, recurrent swelling, or a nodule that develops well after treatment deserves assessment rather than repeated unsupervised massage.
The Adonis guide to lip filler side effects and warning signs explains this distinction specifically for the lips.
Can dermal fillers become infected?
Yes. Infection is less common than swelling or bruising but is a recognized complication.
Possible signs include increasing redness, warmth, tenderness, swelling, drainage, an open sore, or systemic symptoms. The FDA lists infection, open or draining wounds, and injection-site sores among reported filler risks.
Some infections present early. Others may contribute to delayed nodules or recurrent inflammatory episodes, which is another reason diagnosis should come before treatment.
Can filler migrate?
Migration has been reported and is listed by the FDA as a rare risk. It refers to filler material being found away from its intended placement site.
However, not every contour change proves true migration. Overfilling, swelling, tissue descent, or product placed in an unsuitable plane can create a similar appearance.
When the history is unclear or multiple prior treatments are involved, clinical examination and sometimes imaging can help determine what is actually present before more filler is added.
Can an allergic reaction happen after filler?
Yes. Allergic and hypersensitivity reactions are recognized risks, although they are less common than ordinary injection-site effects.
The FDA specifically notes that some filler materials, particularly animal-derived materials, may require allergy testing before treatment. Severe allergic reactions, including anaphylaxis, have also been reported rarely.
Patients should disclose prior reactions to injectables, anesthetics, medications, and known material allergies before treatment.
Can all fillers be dissolved if something goes wrong?
No. This is an important difference between filler categories.
Hyaluronic acid fillers can often be reduced with hyaluronidase. Other materials such as calcium hydroxylapatite, poly-L-lactic acid, and PMMA do not have the same straightforward enzymatic reversal pathway.
The FDA also warns that filler removal may be difficult or impossible, especially with permanent materials or non-HA fillers.
The Adonis guide to filler removal and hyaluronidase explains why even HA reversal is a medical treatment with its own limitations.
Does choosing hyaluronic acid make filler risk-free?
No. Reversibility is useful, but HA filler can still cause vascular occlusion, infection, nodules, delayed inflammation, migration, asymmetry, and other complications.
HA also appears frequently in reports of serious filler complications partly because it is widely used. The AAO vision-loss review found HA in most reported cases it analyzed.
Product category is only one part of risk. Anatomy, treatment area, injection depth, technique, amount injected, previous filler, and the provider's ability to recognize complications all matter.
Does the treatment area change filler risk?
Yes. Facial vascular anatomy differs by region, and some areas have direct or indirect connections that make vascular complications particularly consequential.
The FDA notes that filler injection into the nose, glabella, forehead, periorbital region, and neck is not an approved use of dermal fillers. Off-label medical use can occur, but patients should understand when a proposed treatment is outside an FDA-approved indication.
Before treatment, the exact product and anatomical plan should be clear rather than discussing filler as though every facial region carries the same considerations.
How can you reduce the risk of filler complications?
Risk cannot be reduced to zero, but several principles matter: use a qualified medical provider, identify the exact product, match the product and injection plane to the anatomy, disclose prior fillers and medical history, avoid unnecessary volume, and make sure the clinic has a plan for urgent complications.
For patients comparing current filler options, the Skin Works Medical Spa dermal filler guide explains how product selection, tissue depth, movement, reversibility, and facial anatomy are assessed before treatment.
The Adonis guide to choosing the right filler type also explains why a product should be selected by the anatomical problem and treatment goal rather than brand popularity alone.
When should you call your provider, and when is it an emergency?
Contact the treating provider promptly for symptoms that are persistent, worsening, or unexpected, including increasing redness, warmth, swelling, drainage, significant tenderness, or a new nodule after the area had previously settled.
Seek urgent medical evaluation for severe or escalating pain, white, gray, blue, or mottled skin, sudden visual symptoms, or stroke-like neurologic symptoms.
The distinction is important. A routine two-week filler follow-up is appropriate for ordinary aesthetic review. It is not an appropriate timeline for symptoms that could represent compromised circulation, vision, or neurologic function.
Honest limitation: precise complication rates are difficult to generalize because studies use different products, facial regions, techniques, reporting systems, and follow-up periods. Rare events are often identified through case reports and surveillance rather than trials. Published incidence estimates therefore cannot predict an individual patient's risk.
Frequently Asked Questions
What are the most common dermal filler side effects?
Swelling, bruising, redness, tenderness, pain, itching, and temporary firmness are common. Most occur shortly after injection and improve over several days to weeks. Symptoms that become progressively worse rather than gradually better should be reviewed by the treating provider.
What is the most serious risk of dermal fillers?
Accidental intravascular injection is the most serious recognized filler complication because it can block blood flow. Depending on the vessel involved, this can cause skin necrosis, vision loss, stroke, or other permanent injury.
Can dermal fillers cause blindness?
Yes, although it is uncommon. Filler can enter facial arterial circulation and obstruct blood flow to the retina or optic nerve. Sudden visual symptoms after filler require immediate medical evaluation because published evidence shows that established filler-related vision loss can be difficult to reverse.
Can filler complications happen months later?
Yes. Delayed inflammatory reactions, nodules, swelling, infection, migration, or granulomatous reactions can appear after the initial treatment period. New swelling in a previously settled area should be treated as a new clinical problem rather than routine filler settling.
Can all dermal fillers be dissolved?
No. Hyaluronic acid fillers can often be reduced with hyaluronidase. Calcium hydroxylapatite, poly-L-lactic acid, and PMMA do not have the same straightforward enzymatic reversal method, and permanent filler can be difficult or impossible to remove completely.
What filler symptoms require emergency care?
Severe or rapidly escalating pain, white, gray, blue, or mottled skin, sudden vision changes, loss of vision, or stroke-like symptoms such as weakness or difficulty speaking require urgent medical evaluation. These should not be observed at home as normal post-treatment swelling.
Understand the complication plan before treatment
The surgical team at Adonis Plastic Surgery can assess existing filler when it affects facial surgical planning, review persistent contour concerns, and explain when observation, dissolution, imaging, or another treatment approach may be appropriate.
Request a ConsultationReferences
- U.S. Food and Drug Administration, Dermal Fillers (Soft Tissue Fillers)
- Understanding Vascular Complications Arising From Dermal Filler Injection
- Vision-Threatening Complications of Soft Tissue Fillers: American Academy of Ophthalmology Report
- Understanding Delayed-Onset Inflammatory Responses to Hyaluronic Acid Fillers
Adonis Plastic Surgery is located at 2557 Pacific Coast Highway in Torrance, California, serving patients across the South Bay including Redondo Beach, Palos Verdes Estates, Manhattan Beach, San Pedro, Long Beach, El Segundo, Carson and Gardena.
